Latest News

SEAS welcomes 34 new faculty members
10/28/24
The new faculty bring expertise and interest ranging from software security and electrochemical separations to digital storytelling.
'We were very excited': Researchers at UB working to create vaccine to treat Alzheimer's disease
10/23/24
WKBW-TV quoted Jonathan Lovell in an article about his work developing a vaccine for Alzheimer’s disease. The treatment was effective in mice and the team is moving to gain FDA approval for human testing.
Buffalo Next: UB center gives funding, research assists to health sciences startups
10/7/24
The Buffalo News reported that UB’s Center for Advanced Technology in Big Data and Health Sciences has awarded grants to nine health sciences projects by eight companies, including projects led by Jonathan Lovell and Jun Xia.
POP Biotechnologies Announces Phase 3 Trial Interim Results Published for COVID-19 Vaccine Based on POP BIO SNAP(TM)
9/27/24
The Associated Press reported that POP Biotechnologies, founded by Jonathan Lovell, completed a study on a new recombinant COVID vaccine, EuCorVac-19.
UB CAT announces R&D collaboration awards to eight life sciences companies
9/24/24
Projects focus on cancer therapies, robotic clot removal catheters, and mRNA vaccines, among other technologies
UB SEAS ranked 30th in undergraduate engineering programs among public universities
9/24/24
UB continues to rank among the top public universities in the nation, according to the latest rankings released today by U.S. News & World Report.
Student's ‘crazy’ idea creates opportunity for children of Makhanda
9/10/24
Medical student Anna Walsh started a STEM camp for kindergartners through seventh-graders at a school in South Africa.
UB professor, New York State researchers developing new immunotherapy treatment for Alzheimer’s disease
9/3/24
Promising approach targets multiple pathogenic hallmarks of the disease.

Next>

Latest News

UB Research News

Department of Biomedical Engineering